EP400P1
Putative EP400-like protein
Also known as: E400N_HUMAN
Protein identityUniProt · HPA
OverviewNCBI Gene
No narrative summary is available for EP400P1 in this catalog release; identity and structured annotations are shown without generated factual claims.
Canonical amino-acid sequenceUniProt
488 residues, UniProt reviewed canonical sequence.
>Q6ZTU2|EP400P1
1 MQHVSSSQSS QRHVQWPGAC PGAGEEQPAC SQPSLPLTLP SPSHQLQQLM VRGGPAGGQN
61 MNVDLQGVGP GLQGSPQVTL APLPLPSPTS PGFQFSAQPR RFEHGSPSYI QVTSPLSQQV
121 QTQSPTQPSP GPGQALQNVR AGAPGPGLGL CSSSPTGDFV DASVLVRQIS LSPSSGGHFV
181 FQDGSGLTQI AQGAQVQLQH PGTPITVRER RPSQPHTQSG GTIHHLGPQS PAAAGGAGLQ
241 PLASPSHITT ANLPPQISSI IQGQLVQQQQ VLQGPPLPRP LGFERTPGVL LPGAGGAAGF
301 GMTSPPPPTS PSRTAVPPGL SSLPLTSVGN TGMKKVPKKL EEIPPASPEM AQMRKQCLDY
361 HHQEMQALKE VFKEYLIELF FLQHFQGNMM DFLAFKERLY GPLQAYLRQN DLDIEEEEEE
421 HFEVINDEVK VVARKHGQPG TPVAIATQLP PRTSAAFPAQ QQPLQQIHMG TPVPGDVNSI
481 KMEASKRQLocalizationUniProt · AlphaFold · HPA
Whether an antibody against EP400P1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.68
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads EP400P1 as an antibody target. Whether an autoantibody or antibody against EP400P1 could matter depends on whether native EP400P1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
EP400P1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label EP400P1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...